Free tool
FAERS Monitor: Sporanox
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020694 or its brand name (Sporanox, Itraconazole). Reports on generic versions are filed under their own applications.
Reports
11,784
Serious
10,489
89% of reports
Hospitalization
4,471
Death reported
2,277
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug interaction1,191
- drug ineffective1,144
- off label use632
- pyrexia589
- dyspnoea493
- pneumonia484
- nausea468
- diarrhoea404
- condition aggravated400
- febrile neutropenia373
- fatigue351
- rash310
- anaemia303
- neutropenia302
- cough295
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 277 |
| 2005 | 192 |
| 2006 | 219 |
| 2007 | 254 |
| 2008 | 291 |
| 2009 | 408 |
| 2010 | 361 |
| 2011 | 621 |
| 2012 | 587 |
| 2013 | 409 |
| 2014 | 373 |
| 2015 | 610 |
| 2016 | 474 |
| 2017 | 517 |
| 2018 | 703 |
| 2019 | 826 |
| 2020 | 868 |
| 2021 | 782 |
| 2022 | 676 |
| 2023 | 676 |
| 2024 | 601 |
| 2025 | 566 |
| 2026 | 492 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,375 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug interactionSignal | 1,191 | 13.5 | 12.8 | 13,765 |
| febrile neutropeniaSignal | 373 | 10.1 | 9.1 | 3,037 |
| neutropeniaSignal | 302 | 4.0 | 3.6 | 671 |
| pyrexiaSignal | 589 | 3.0 | 2.8 | 817 |
| anaemiaSignal | 303 | 2.8 | 2.5 | 362 |
| pneumoniaSignal | 484 | 2.7 | 2.4 | 511 |
| condition aggravatedSignal | 400 | 2.4 | 2.1 | 313 |
| cough | 295 | 1.9 | 1.7 | 122 |
| dyspnoea | 493 | 1.6 | 1.4 | 100 |
| drug ineffective | 1,144 | 1.5 | 1.5 | 237 |
| off label use | 632 | 1.3 | 1.2 | 42 |
| rash | 310 | 1.3 | 1.1 | 18 |
| diarrhoea | 404 | 1.1 | 1.0 | 5 |
| nausea | 468 | 1.1 | 1.0 | 1 |
| fatigue | 351 | 0.8 | 0.7 | 17 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.